Fig. 8From: Integrative analysis of m3C associated genes reveals METTL2A as a potential oncogene in breast CancerThe potential therapeutic agents for METTL2A high expression BRCA patients. Volcano plot and violin plot of differential drug response analysis in a, b PRISM and c, d GDSC between METTL2A high expression (top decile) and low expression (bottom decile) groupBack to article page